The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway
暂无分享,去创建一个
[1] G. Wang,et al. The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway , 2014, Cancer Cell International.
[2] P. Kaldis,et al. Cdks, cyclins and CKIs: roles beyond cell cycle regulation , 2013, Development.
[3] M. Hung,et al. Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression , 2013, Cell.
[4] R. Agarwal,et al. Poly[3-(3, 4-dihydroxyphenyl) glyceric acid] from Comfrey exerts anti-cancer efficacy against human prostate cancer via targeting androgen receptor, cell cycle arrest and apoptosis. , 2012, Carcinogenesis.
[5] J. Hazle,et al. The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis , 2012, Cell.
[6] R. Agarwal,et al. Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells. , 2012, Carcinogenesis.
[7] A. Marks,et al. Rapamycin resistance is linked to defective regulation of Skp2. , 2012, Cancer research.
[8] Zhiwei Wang,et al. Skp2 is a Promising Therapeutic Target in Breast Cancer , 2011, Front. Oncol..
[9] R. Pearson,et al. Targeting PI3 kinase/AKT/mTOR signaling in cancer. , 2012, Critical reviews in oncogenesis.
[10] Joshua M. Stuart,et al. Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.
[11] ChuHee Lee,et al. Curcumin Induces Downregulation of E2F4 Expression and Apoptotic Cell Death in HCT116 Human Colon Cancer Cells; Involvement of Reactive Oxygen Species. , 2010, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.
[12] S. Katiyar,et al. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. , 2010, Carcinogenesis.
[13] J. Vadgama,et al. FOXO1A is a target for HER2-overexpressing breast tumors. , 2010, Cancer research.
[14] W. Muller,et al. Distinct biological roles for the akt family in mammary tumor progression. , 2010, Cancer research.
[15] J. Salvador,et al. The dark side of curcumin , 2010, International journal of cancer.
[16] G. Russo,et al. Phytochemicals in Cancer Prevention and Therapy: Truth or Dare? , 2010, Toxins.
[17] S. Meloche,et al. Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2 , 2010, Cell cycle.
[18] M. Pagano,et al. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization , 2010, Cell cycle.
[19] Serge Eifes,et al. Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment , 2010, Toxins.
[20] C. Su,et al. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. , 2009, International journal of molecular medicine.
[21] L. Hengst,et al. Skp2: caught in the Akt , 2009, Nature Cell Biology.
[22] A. Toker,et al. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction , 2009, Nature Cell Biology.
[23] P. Pandolfi,et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB , 2009, Nature Cell Biology.
[24] Jen-kun Lin,et al. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. , 2008, Endocrinology.
[25] M. López-Lázaro. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. , 2008, Molecular nutrition & food research.
[26] D. Hershko,et al. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer , 2008, Cancer.
[27] B. Aggarwal,et al. Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.
[28] Yan-bin Zhao,et al. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin. , 2007, Acta biochimica et biophysica Sinica.
[29] N. Ahmad,et al. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer. , 2007, Toxicology and applied pharmacology.
[30] Sanjeev Banerjee,et al. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. , 2007, Biochemical pharmacology.
[31] G. Tchernev,et al. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl‐2‐related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings , 2007, Journal of cutaneous pathology.
[32] B. Aggarwal,et al. From kitchen to clinic , 2007 .
[33] C. Gladson,et al. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.
[34] E. Kakiashvili,et al. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells , 2006, Breast Cancer Research.
[35] K. Pumiglia,et al. Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent Mechanisms , 2006, Molecular and Cellular Biology.
[36] H. Kreipe,et al. Prognostic impact of Skp2 and p27 in human breast cancer , 2006, Breast Cancer Research and Treatment.
[37] T. Utsunomiya,et al. Significance of skp2 expression in primary breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] N. Ahmad,et al. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells. , 2006, Cancer research.
[39] K. Harada,et al. Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells. , 2005, Oral oncology.
[40] K. Nakayama,et al. Regulation of the cell cycle by SCF-type ubiquitin ligases. , 2005, Seminars in cell & developmental biology.
[41] Steven F Dowdy,et al. Cip/Kip proteins: more than just CDKs inhibitors. , 2004, Genes & development.
[42] K. Nakayama,et al. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] Yi Sun,et al. Targeting E3 Ubiquitin Ligases for Cancer Therapy , 2003, Cancer biology & therapy.
[44] J. Slingerland,et al. Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.
[45] J. Inazawa,et al. Down‐regulation of SKP2 induces apoptosis in lung‐cancer cells , 2003, Cancer science.
[46] S. Ramaswamy,et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. , 2002, The Journal of clinical investigation.
[47] R. Orlowski,et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. , 2002, Cancer research.
[48] Zhen-zhou Shen,et al. Curcumin exerts multiple suppressive effects on human breast carcinoma cells , 2002, International journal of cancer.
[49] Z. Fan,et al. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells , 2001, Oncogene.
[50] Brian A. Hemmings,et al. Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.
[51] J. Slingerland,et al. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[52] B. Aggarwal,et al. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. , 1997, Anti-Cancer Drugs.
[53] N. Vermeulen,et al. Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.